Buy Max Healthcare Institute, target price Rs 530: Motilal Oswal Financial Services
The company is well placed to benefit from the opportunities given it is strategically located in metro cities and possesses strong execution capabilities.
By ETMarkets.com | Updated:
IANS
Motilal Oswal Financial Services has buy call on Max Healthcare Institute with a target price of Rs 530.The current market price of Max Healthcare Institute is Rs 449.4.
Max Healthcare Institute, incorporated in the year 2001, is a Small Cap company (having a market cap of Rs 43663.14 Crore) operating in Hospitals & Allied Services sector.
Max Healthcare Institute key Products/Revenue Segments include HealthCare Services, Drugs & Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.
Financials
For the quarter ended 31-12-2022, the company has reported a Consolidated Total Income of Rs 1186.39 Crore, up 2.02 % from last quarter Total Income of Rs 1162.94 Crore and up 16.00 % from last year same quarter Total Income of Rs 1022.77 Crore. Company has reported net profit after tax of Rs 222.41 Crore in latest quarter.
The company’s top management includes Mr.Abhay Soi, Mr.Prashant Kumar, Mr.Anil Bhatnagar, Mr.Pranav Amin, Mr.Michael Thomas Neeb, Mr.Mahendra Gumanmalji Lodha, Ms.Harmeen Mehta, Mr.K Narasimha Murthy. Company has S R Batliboi & Co. LLP as its auditors. As on 31-12-2022, the company has a total of 97 Crore shares outstanding.
Investment Rationale
The demand factors for the hospital/diagnostic industry in India remain favorable aided by rising income, healthcare needs and higher health insurance penetration. The company is well placed to benefit from the opportunities given it is strategically located in metro cities and possesses strong execution capabilities.
Promoter/FII Holdings
Promoters held 23.78 per cent stake in the company as of 31-Dec-2022, while FIIs owned 50.15 per cent, DIIs 20.47 per cent.
Max Healthcare Institute, incorporated in the year 2001, is a Small Cap company (having a market cap of Rs 43663.14 Crore) operating in Hospitals & Allied Services sector.
Max Healthcare Institute key Products/Revenue Segments include HealthCare Services, Drugs & Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.
Financials
For the quarter ended 31-12-2022, the company has reported a Consolidated Total Income of Rs 1186.39 Crore, up 2.02 % from last quarter Total Income of Rs 1162.94 Crore and up 16.00 % from last year same quarter Total Income of Rs 1022.77 Crore. Company has reported net profit after tax of Rs 222.41 Crore in latest quarter.
The company’s top management includes Mr.Abhay Soi, Mr.Prashant Kumar, Mr.Anil Bhatnagar, Mr.Pranav Amin, Mr.Michael Thomas Neeb, Mr.Mahendra Gumanmalji Lodha, Ms.Harmeen Mehta, Mr.K Narasimha Murthy. Company has S R Batliboi & Co. LLP as its auditors. As on 31-12-2022, the company has a total of 97 Crore shares outstanding.
Investment Rationale
The demand factors for the hospital/diagnostic industry in India remain favorable aided by rising income, healthcare needs and higher health insurance penetration. The company is well placed to benefit from the opportunities given it is strategically located in metro cities and possesses strong execution capabilities.
ADVERTISEMENT
Promoter/FII Holdings
Promoters held 23.78 per cent stake in the company as of 31-Dec-2022, while FIIs owned 50.15 per cent, DIIs 20.47 per cent.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
